Gapping up
In reaction to strong earnings/guidance: ASX +0.8% (ticking higher).
M&A news: IDIX +236.5% (to be acquired by Merck (MRK) for $24.50 per share in cash), HITT +29% (to be acquired by Analog Devices (ADI) for $78 per share in cash), HSH +4.9% (Tyson Foods (TSN) confirms binding offer to acquire all outstanding shares of HSH for $63/share).
Select metals/mining stocks trading higher: GG +1.5%, GOLD +0.7%, SLV +0.7%, MT +0.7%, EOG +0.6%, BHP +0.4%.
Other news: ACHN +38.5% (IDIX peer), FDO +13.2% (Carl Icahn discloses 9.4% active stake in FDO; intends to have conversations with mgmt), CGIX +5.5% (announces partnership with AZN to provide biomarker & molecular based testing), RDNT +5.3% (announced that it has joined with WellMatch to collaborate and help launch a new online service for its imaging centers), SQNM +5.1% (announces third national coverage agreement for prenatal diagnostic testing servides), BDSI +4% (received FDA approval for BUNAVAIL Buccal Film for the maintenance treatment of opioid dependence), ODP +3.8% (positive Barrons mention), PF +3.3% (related to HSH/TSN news), GBLX +3.1% (secured special use permit for medical marijuana establishment in Clark County, Nevada), OREX+2.8% (Biotech peer), ARIA +2.4% (IDIX peers), BKS +1.5% (headlines over the weekend that BKS & AVGO's LSI have ended Nook related lawsuits), TEVA +1.1% (FDA approves expanded label for AZILECT for treatment across all stages of parkinson's disease), MTOR +1% (Sandell Asett Mgmt discloses 5.1% stake in 13D ), HK +0.9% (provides an operational update in the Tuscaloosa Marine Shale; announced the signing of a definitive agreement with credit funds and accounts).
Analyst comments: DG +8.7% (mentioned positively at BofA/Merill related to positive developments with Coupon.com (COUP) and upgraded to Buy from Hold at Jefferies), ARCO +5.1% (upgraded to Buy from Underperform at BofA/Merrill), BMRN +1.4% (upgraded to Outperform from Neutral at Credit Suisse), WETF +1.1% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
In reaction to strong earnings/guidance: ASX +0.8% (ticking higher).
M&A news: IDIX +236.5% (to be acquired by Merck (MRK) for $24.50 per share in cash), HITT +29% (to be acquired by Analog Devices (ADI) for $78 per share in cash), HSH +4.9% (Tyson Foods (TSN) confirms binding offer to acquire all outstanding shares of HSH for $63/share).
Select metals/mining stocks trading higher: GG +1.5%, GOLD +0.7%, SLV +0.7%, MT +0.7%, EOG +0.6%, BHP +0.4%.
Other news: ACHN +38.5% (IDIX peer), FDO +13.2% (Carl Icahn discloses 9.4% active stake in FDO; intends to have conversations with mgmt), CGIX +5.5% (announces partnership with AZN to provide biomarker & molecular based testing), RDNT +5.3% (announced that it has joined with WellMatch to collaborate and help launch a new online service for its imaging centers), SQNM +5.1% (announces third national coverage agreement for prenatal diagnostic testing servides), BDSI +4% (received FDA approval for BUNAVAIL Buccal Film for the maintenance treatment of opioid dependence), ODP +3.8% (positive Barrons mention), PF +3.3% (related to HSH/TSN news), GBLX +3.1% (secured special use permit for medical marijuana establishment in Clark County, Nevada), OREX+2.8% (Biotech peer), ARIA +2.4% (IDIX peers), BKS +1.5% (headlines over the weekend that BKS & AVGO's LSI have ended Nook related lawsuits), TEVA +1.1% (FDA approves expanded label for AZILECT for treatment across all stages of parkinson's disease), MTOR +1% (Sandell Asett Mgmt discloses 5.1% stake in 13D ), HK +0.9% (provides an operational update in the Tuscaloosa Marine Shale; announced the signing of a definitive agreement with credit funds and accounts).
Analyst comments: DG +8.7% (mentioned positively at BofA/Merill related to positive developments with Coupon.com (COUP) and upgraded to Buy from Hold at Jefferies), ARCO +5.1% (upgraded to Buy from Underperform at BofA/Merrill), BMRN +1.4% (upgraded to Outperform from Neutral at Credit Suisse), WETF +1.1% (upgraded to Overweight from Equal-Weight at Morgan Stanley)